In The News
Class action firm breaches costs disclosure rules again, argues against penalty
Court won’t suppress name of barrister accused of sexual harassment
Class action against Phoslock, KPMG should not wait for competing case, court told
Deputy Prime Minister sued by chief of staff who complained about bullying
Pacific Werribee shopping centre owners get preliminary trial in $200M defects dispute
Angus & Julia Stone’s claims against management company sent to UK
Albanese government dumps misinformation bill
Katy Perry wins appeal in trade mark fight with Aussie designer
Lawyers in NSW can’t use AI to generate affidavits, witness statements, court says
Group members get nothing in RoundUp class action settlement
Please login to bookmarkClose

IP Australia handed a win Thursday to a company challenging a Bayer animal drug patent, but gave Bayer an additional two months to address its concerns about the patent application’s deficiencies.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au